+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Botulinum toxin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4701638
  • Report
  • August 2018
  • Region: Global
  • Acute Market Reports
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc.
  • Elan Pharmaceuticals
  • Ipsen Group
  • Medytox, Inc.
  • Speywood Pharmaceuticals
  • US Worldmeds,LLC
  • MORE
Botulinum toxin Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 the botulinum toxin market was valued at US$ 3,672.4 Mn in 2017 and expected to grow at a CAGR of 7.2 % during the forecast period from 2018 to 2026.

Market Insights
The global botulinum toxin market shows productive growth during the forecast period from 2018 to 2026, attributed to its wide usage in cosmetic and therapeutic applications. Common types are botulinum toxin A (BNT-A), and botulinum toxin B (BNT-B). Botox injections or drugs made from a neurotoxin produced by the bacterium clostridium botulinum. Doctors or dermatology specialists use botulinum toxins in very small doses to treat numerous health problems such as smoothing of facial wrinkles, cervical dystonia (neurological disorder), blepharospasm, overactive bladder, upper limb or lower limb spasticity, strabismus, tremor, hypersecretory disorders and others. BNT Type A trade names in the U.S. are mainly sold as Botox, Dysport and Xeomin (commercially available) and type B trade names are Myobloc and Neurobloc. Botulinum toxin B is U.S FDA approved for treatment against cervical dystonia and hemifacial spasm (HFS).
Consistent innovation along with top cosmetic applications to give productive restorative intervention to a large group of diseases has supported the overall growth of the market. A few botulinum toxins (BNT) are in clinical stage and anticipated to drive the market in the coming years. The prominent growth factors include increasing cosmetic and therapeutic procedures worldwide, FDA approval of botulinum treatments, higher efficacy, increasing geriatric population, increasing awareness, offers potential advantage as an elective treatment to high cost medical/surgical procedures, and wide usage of top applications in the cosmetic industry.
In any case, safety issues in treatment and in general potential lethality, high financial investment and expensive medications, strict administrative rules, and reimbursement approach issues are the key components limiting the market growth during the forecast period. In addition, the worldwide monetary conditions in the healthcare sector in developing economies make a noteworthy open door for the extension of the market.

Key Market Movements:
  • Globally, the botulinum toxin market remains to exhibit a profitable growth with a CAGR of 7.2% for the period from 2018 to 2026
  • The BNT type A segment shows lucrative growth with increasing applications in the cosmetic and therapeutic procedures
  • The development of the worldwide botulinum toxin market is mainly attributed to high pervasiveness of the neurological disorders, higher adoption of BNT injections in the end user segment and higher technological advancements in the products, with increased efficacy along with less side effects during the course of treatment
  • North America to contribute maximum revenue share in the overall growth of the botulinum toxin market, attributed to rising cosmetic & surgical procedures, broad utilization of BNT type A & B in the treatment of cosmetic applications such as forehead lines, crow's feet, square jaw/masseter, frown lines, and others
  • Increasing awareness and programs held by top trained and skilled dermatology professionals, maximum reimbursement coverage, increasing inclination towards cosmetic procedures, ageing population and the presence of top key botulinum manufacturers & sophisticated healthcare infrastructure in the developing nations are few of the external factors driving the growth of the market.
  • Eastern Europe, Latin America, and Asia Pacific to show promising opportunities and demonstrate growing CAGR during the forecast period owing to rising awareness among the individuals about the concerns for botulinum toxin and its utilization
  • Surging population & growing number of advanced healthcare settings, availability of branded product types, and increasing healthcare spending in Russia, Brazil, India, China, and Japan may contribute the growth of the market during the forecast period
  • Major players in this vertical are Allergan Plc., Speywood Pharmaceuticals, Merz Pharma GmbH & Co. KGaA, Lanzhou Biological Products Institute, Elan Pharmaceuticals, Revance Therapeutics, Inc., Medytox, Inc., US Worldmeds, LLC, Lanzhou Institute of Biological Products Co. Ltd. Ipsen Group and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc.
  • Elan Pharmaceuticals
  • Ipsen Group
  • Medytox, Inc.
  • Speywood Pharmaceuticals
  • US Worldmeds,LLC
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
1.3. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Botulinum Toxin Market Portraiture
2.2. Global Botulinum Toxin Market, By Product Type, 2017 (US$ Mn)
2.3. Global Botulinum Toxin Market, By Application, 2017 (US$ Mn)
2.4. Global Botulinum Toxin Market, By End User, 2017 (US$ Mn)
2.5. Global Botulinum Toxin Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Botulinum Toxin Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Botulinum Toxin: Future Trends
3.3. Current Scenario: Strategies Used for Drug Delivery Across BBB Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Botulinum Toxin Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Botulinum toxin A (BNT-A)
4.3. Botulinum toxin B (BNT-B)

Chapter 5. Global Botulinum Toxin Market, By Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Cosmetics
5.3. Neurological Disorders
5.4. Other Therapeutic Areas

Chapter 6. Global Botulinum Toxin Market, By End User, 2016 – 2026 (US$)
6.1. Overview
6.2. Hospitals
6.3. Dermatology & Beauty Clinics
6.4. Spas & Cosmetic Centers

Chapter 7. Global Botulinum Toxin Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America Botulinum Toxin Market Analysis, 2016 – 2026
7.2.1. North America Botulinum Toxin Market, By Product Type, 2016 – 2026 (US$ Mn)
7.2.2. North America Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
7.2.3. North America Botulinum Toxin Market, By End User, 2016 – 2026 (US$ Mn)
7.2.4. North America Botulinum Toxin Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Botulinum Toxin Market Analysis, 2016 – 2026
7.3.1. Europe Botulinum Toxin Market, By Product Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
7.3.3. Europe Botulinum Toxin Market, By End User, 2016 – 2026 (US$ Mn)
7.3.4. Europe Botulinum Toxin Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Botulinum Toxin Market Analysis, 2016 – 2026
7.4.1. Asia Pacific Botulinum Toxin Market, By Product Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific Botulinum Toxin Market, By End User, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific Botulinum Toxin Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America Botulinum Toxin Market Analysis, 2016 – 2026
7.5.1. Latin America Botulinum Toxin Market, By Product Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
7.5.3. Latin America Botulinum Toxin Market, By End User, 2016 – 2026 (US$ Mn)
7.5.4. Latin America Botulinum Toxin Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Botulinum Toxin Market Analysis, 2016 – 2026
7.6.1. MEA Botulinum Toxin Market, by Product Type, 2016 – 2026 (US$ Mn)
7.6.2. MEA Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
7.6.3. MEA Botulinum Toxin Market, By End User, 2016 – 2026 (US$ Mn)
7.6.4. MEA Botulinum Toxin Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Allergan Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Speywood Pharmaceuticals
8.3. Merz Pharma GmbH & Co. KGaA
8.4. Elan Pharmaceuticals
8.5. Revance Therapeutics, Inc.
8.6. Medytox, Inc.
8.7. US Worldmeds,LLC
8.8. Lanzhou Institute of Biological Products Co.Ltd.
8.9. Ipsen Group

List of Figures
FIG. 1 Global Botulinum Toxin Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Botulinum Toxin Market Segmentation
FIG. 4 Global Botulinum Toxin Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global Botulinum Toxin Market, By Application, 2016 – 2026 (US$ Mn)
FIG. 6 Global Botulinum Toxin Market, by End User, 2017 (US$ Mn)
FIG. 7 Global Botulinum Toxin Market, by Geography, 2017 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key Botulinum Toxin Manufacturers, 2017
FIG. 10 Global BNT Type A Market, 2016–2026 (US$ Mn)
FIG. 11 Global BNT Type B Market, 2016–2026 (US$ Mn)
FIG. 12 Global Botulinum Toxin Market for Neurological Disorders , 2016–2026 (US$ Mn)
FIG. 13 Global Botulinum Toxin Market for Cosmetics, 2016–2026 (US$ Mn)
FIG. 14 Global Botulinum Toxin Market for Other Therapeutic Areas, 2016–2026 (US$ Mn)
FIG. 15 Global Hospitals Market for Botulinum Toxin, 2016–2026 (US$ Mn)
FIG. 16 Global Dermatology & Beauty Clinics Market for Botulinum Toxin, 2016–2026 (US$ Mn)
FIG. 17 Global Spas & Cosmetic Centers Market for Botulinum Toxin, 2016–2026 (US$ Mn)
FIG. 18 U.S. Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 19 Canada Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 20 U.K. Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 21 Germany Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 22 Rest of Europe Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 23 Japan Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 24 China Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 26 Brazil Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 27 Mexico Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 28 Rest of Latin America Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 29 GCC Botulinum Toxin Market, 2016–2026 (US$ Mn)
FIG. 30 Rest of Middle East & Africa Botulinum Toxin Market, 2016–2026 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Botulinum Toxin Market
TABLE 2 Global Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 3 Global Botulinum Toxin Market, by Application, 2016–2026 (US$ Mn)
TABLE 4 Global Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 5 Global Botulinum Toxin Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 North America Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 7 North America Botulinum Toxin Market, by Application, 2016–2026 (US$ Mn)
TABLE 8 North America Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 9 North America Botulinum Toxin Market, by Country, 2016–2026 (US$ Mn)
TABLE 10 Europe Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 11 Europe Botulinum Toxin Market, by Application, 2016–2026 (US$ Mn)
TABLE 12 Europe Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 Europe Botulinum Toxin Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Latin America Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 15 Latin America Botulinum Toxin Market, by Application, 2016–2026 (US$ Mn)
TABLE 16 Latin America Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 17 Latin America Botulinum Toxin Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 18 Asia Pacific Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 19 Asia Pacific Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 20 Asia Pacific Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 21 Asia Pacific Botulinum Toxin Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 22 Middle East & Africa Botulinum Toxin Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 23 Middle East & Africa Botulinum Toxin Market, by Application, 2016–2026 (US$ Mn)
TABLE 24 Middle East & Africa Botulinum Toxin Market, by End User, 2016–2026 (US$ Mn)
TABLE 25 Middle East & Africa Botulinum Toxin Market, by Region, 2016–2026 (US$ Mn)
TABLE 26 Allergan Plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Speywood Pharmaceuticals: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Merz Pharma GmbH & Co. KGaA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Elan Pharmaceuticals.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Revance Therapeutics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Medytox, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 US Worldmed, LLC: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Lanzhou Institute of Biological Products Co.Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Ipsen Group: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc.
  • Speywood Pharmaceuticals
  • Merz Pharma GmbH & Co. KGaA
  • Elan Pharmaceuticals
  • Revance Therapeutics, Inc.
  • Medytox, Inc.
  • US Worldmeds,LLC
  • Lanzhou Institute of Biological Products Co.Ltd.
  • Ipsen Group
Note: Product cover images may vary from those shown
Adroll
adroll